These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9818746)

  • 61. Design, chemical synthesis of 3-(9H-fluoren-9-yl)pyrrolidine-2,5-dione derivatives and biological activity against enoyl-ACP reductase (InhA) and Mycobacterium tuberculosis.
    Matviiuk T; Rodriguez F; Saffon N; Mallet-Ladeira S; Gorichko M; de Jesus Lopes Ribeiro AL; Pasca MR; Lherbet C; Voitenko Z; Baltas M
    Eur J Med Chem; 2013; 70():37-48. PubMed ID: 24140915
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Synthesis and antituberculosis action of some new pyruvic acid derivatives.
    Ungureanu M; Diculencu D; Archip C
    Rev Med Chir Soc Med Nat Iasi; 2008; 112(3):860-4. PubMed ID: 20201282
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A novel inhibitor of indole-3-glycerol phosphate synthase with activity against multidrug-resistant Mycobacterium tuberculosis.
    Shen H; Wang F; Zhang Y; Huang Q; Xu S; Hu H; Yue J; Wang H
    FEBS J; 2009 Jan; 276(1):144-54. PubMed ID: 19032598
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Expression of katG in Mycobacterium tuberculosis is associated with its growth and persistence in mice and guinea pigs.
    Li Z; Kelley C; Collins F; Rouse D; Morris S
    J Infect Dis; 1998 Apr; 177(4):1030-5. PubMed ID: 9534978
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Activity of IQG-607, a new orally active compound, in a murine model of Mycobacterium tuberculosis infection.
    Rodrigues-Junior VS; Dos Santos Junior A; Dos Santos AJ; Schneider CZ; Calixto JB; Sousa EH; de França Lopes LG; Souto AA; Basso LA; Santos DS; Campos MM
    Int J Antimicrob Agents; 2012 Aug; 40(2):182-5. PubMed ID: 22748570
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Biochemical and functional characterization of
    Singh N; Chauhan A; Kumar R; Singh SK
    Microbiology (Reading); 2021 Sep; 167(9):. PubMed ID: 34515631
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Global expression profiling of yeast treated with an inhibitor of amino acid biosynthesis, sulfometuron methyl.
    Jia MH; Larossa RA; Lee JM; Rafalski A; Derose E; Gonye G; Xue Z
    Physiol Genomics; 2000 Aug; 3(2):83-92. PubMed ID: 11015603
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Novel N-aryl- and N-heteryl phenazine-1-carboxamides as potential agents for the treatment of infections sustained by drug-resistant and multidrug-resistant Mycobacterium tuberculosis.
    De Logu A; Palchykovska LH; Kostina VH; Sanna A; Meleddu R; Chisu L; Alexeeva IV; Shved AD
    Int J Antimicrob Agents; 2009 Mar; 33(3):223-9. PubMed ID: 19070992
    [TBL] [Abstract][Full Text] [Related]  

  • 69.
    Heinrichs MT; May RJ; Heider F; Reimers T; B Sy SK; Peloquin CA; Derendorf H
    Int J Mycobacteriol; 2018; 7(2):156-161. PubMed ID: 29900893
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Unraveling the role of fermentation in the mode of action of acetolactate synthase inhibitors by metabolic profiling.
    Zabalza A; Orcaray L; Igal M; Schauer N; Fernie AR; Geigenberger P; van Dongen JT; Royuela M
    J Plant Physiol; 2011 Sep; 168(13):1568-75. PubMed ID: 21529995
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Durable cure for tuberculosis: rifalazil in combination with isoniazid in a murine model of Mycobacterium tuberculosis infection.
    Shoen CM; DeStefano MS; Cynamon MH
    Clin Infect Dis; 2000 Jun; 30 Suppl 3():S288-90. PubMed ID: 10875802
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Rapid, simple in vivo screen for new drugs active against Mycobacterium tuberculosis.
    Nikonenko BV; Samala R; Einck L; Nacy CA
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4550-5. PubMed ID: 15561824
    [TBL] [Abstract][Full Text] [Related]  

  • 73. In vitro susceptibility testing of Mycobacterium tuberculosis complex strains isolated from seals to antituberculosis drugs.
    Bernardelli A; Morcillo N; Loureiro J; Quse V; Davenport S
    Biomedica; 2004 Jun; 24 Supp 1():85-91. PubMed ID: 15495576
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A novel amino acid substitution Trp574Arg in acetolactate synthase (ALS) confers broad resistance to ALS-inhibiting herbicides in crabgrass (Digitaria sanguinalis).
    Li J; Li M; Gao X; Fang F
    Pest Manag Sci; 2017 Dec; 73(12):2538-2543. PubMed ID: 28643897
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Mycobacterium tuberculosis gyrase inhibitors as a new class of antitubercular drugs.
    Blanco D; Perez-Herran E; Cacho M; Ballell L; Castro J; González Del Río R; Lavandera JL; Remuiñán MJ; Richards C; Rullas J; Vázquez-Muñiz MJ; Woldu E; Zapatero-González MC; Angulo-Barturen I; Mendoza A; Barros D
    Antimicrob Agents Chemother; 2015 Apr; 59(4):1868-75. PubMed ID: 25583730
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Purified recombinant Escherichia coli ketol-acid reductoisomerase is unsuitable for use in a coupled assay of acetohydroxyacid synthase activity due to an unexpected side reaction.
    Hill CM; Duggleby RG
    Protein Expr Purif; 1999 Feb; 15(1):57-61. PubMed ID: 10024470
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis.
    Andries K; Verhasselt P; Guillemont J; Göhlmann HW; Neefs JM; Winkler H; Van Gestel J; Timmerman P; Zhu M; Lee E; Williams P; de Chaffoy D; Huitric E; Hoffner S; Cambau E; Truffot-Pernot C; Lounis N; Jarlier V
    Science; 2005 Jan; 307(5707):223-7. PubMed ID: 15591164
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cloning and sequencing of the ilvBNC gene cluster from Mycobacterium avium.
    Gusberti L; Cantoni R; De Rossi E; Branzoni M; Riccardi G
    Gene; 1996 Oct; 177(1-2):83-5. PubMed ID: 8921849
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Postantibiotic effects of antituberculosis agents alone and in combination.
    Chan CY; Au-Yeang C; Yew WW; Hui M; Cheng AF
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3631-4. PubMed ID: 11709357
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Synthesis, bioactivity and SAR study of N'-(5-substituted-1,3,4-thiadiazol-2-yl)-N-cyclopropylformyl-thioureas as ketol-acid reductoisomerase inhibitors.
    Liu XH; Zhang CY; Guo WC; Li YH; Chen PQ; Wang T; Dong WL; Wang BL; Sun HW; Li ZM
    J Enzyme Inhib Med Chem; 2009 Apr; 24(2):545-52. PubMed ID: 18763167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.